QA: ENDONOVO THERAPEUTICS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001528172_2023_ENDONOVO_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001528172, ENDONOVO THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 15,822
1 IntangibleAssetsNetIncludingGoodwill 1,265,444
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 33,381,760
5 LiabilitiesNoncurrent 79,825
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 9,990
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 3,389,705
11 remainder_Revenues 135,355
12 remainder_NetIncome -15,210,495
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,281,266
1 Liabilities 33,461,585
2 Expenses 3,399,695
3 Revenues 135,355
4 StockholdersEquity -32,180,319
5 NetIncome -18,474,835
6 ComprehensiveNetIncome -18,474,835
7 BaseVar 26,744,198
8 EconomicCapitalRatio -4.25

Edgar->Model Mapping

Feature Distribution

Change over Time